LV-CAG-Cre-P2A-GFP

Price: $468.00

Add to Cart:

  • Catalog #: SL100373
  • Unit Size: 2 x 25 µL (>10^9 TU/mL)

Please Choose:



Pre-made recombinant lentivirus | LV-CAG-Cre-P2A-GFP | LV-CBA-Cre-P2A-GFP | CAG-Cre-P2A-GFP Lentivirus | CBA-Cre-P2A-GFP Lentivirus

Product Category: Pre-made recombinant lentivirus | LV-CAG-Cre-P2A-GFP | LV-CBA-Cre-P2A-GFP | CAG-Cre-P2A-GFP Lentivirus | CBA-Cre-P2A-GFP Lentivirus

Description: Cre recombinase is a type I topoisomerase from bacteriophage P1 that catalyzes the site-specific recombination of DNA between loxP sites.  Cre recombinase is used as a tool to genetically modify genes, such as to delete a segment of DNA flanked by LoxP sites in cells or experimental animals.

This pre-made lentivirus LV-CAG-Cre-P2A-GFP co-expresses Cre recombinase and GFP as reporter under CAG promoter (also known as CBA promoter) via the P2A linker.  Ready to use format.

Titer: > 1x10TU/mL

Selection Antibiotic: None

Purity*: In vivo grade and OK for both in vitro tissue culture infection and in vivo injection

Size: 2 x 25 µL (Std Pack)

Storage Buffer: PBS

Infection Protocol: 


Transfer Vector Map:
Pre-made recombinant lentivirus | LV-CAG-Cre-P2A-GFP | LV-CBA-Cre-P2A-GFP | CAG-Cre-P2A-GFP Lentivirus | CBA-Cre-P2A-GFP Lentivirus


* Concentrated via PEG precipitation followed by ultra-centrifugation at 25000 rpm


 




Copyright © 2025 SignaGen Laboratories. All Rights Reserved.